Clinical Trial Update: Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer [NA]

View source ↗

Summary

An update on the experience of a patient treated with trastuzumab (Herceptin) as adjuvant therapy for breast cancer in a completed clinical trial. The trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Breast Cancer | NA | Status: COMPLETED